Sustained Weight Loss and Risk of Breast Cancer in Women 50 Years and Older: A Pooled Analysis of Prospective Data
- PMID: 31845728
- PMCID: PMC7492760
- DOI: 10.1093/jnci/djz226
Sustained Weight Loss and Risk of Breast Cancer in Women 50 Years and Older: A Pooled Analysis of Prospective Data
Abstract
Background: Excess body weight is an established cause of postmenopausal breast cancer, but it is unknown if weight loss reduces risk.
Methods: Associations between weight change and risk of breast cancer were examined among women aged 50 years and older in the Pooling Project of Prospective Studies of Diet and Cancer. In 10 cohorts, weight assessed on three surveys was used to examine weight change patterns over approximately 10 years (interval 1 median = 5.2 years; interval 2 median = 4.0 years). Sustained weight loss was defined as no less than 2 kg lost in interval 1 that was not regained in interval 2. Among 180 885 women, 6930 invasive breast cancers were identified during follow-up.
Results: Compared with women with stable weight (±2 kg), women with sustained weight loss had a lower risk of breast cancer. This risk reduction was linear and specific to women not using postmenopausal hormones (>2-4.5 kg lost: hazard ratio [HR] = 0.82, 95% confidence interval [CI] = 0.70 to 0.96; >4.5-<9 kg lost: HR = 0.75, 95% CI = 0.63 to 0.90; ≥9 kg lost: HR = 0.68, 95% CI = 0.50 to 0.93). Women who lost at least 9 kg and gained back some (but not all) of it were also at a lower risk of breast cancer. Other patterns of weight loss and gain over the two intervals had a similar risk of breast cancer to women with stable weight.
Conclusions: These results suggest that sustained weight loss, even modest amounts, is associated with lower breast cancer risk for women aged 50 years and older. Breast cancer prevention may be a strong weight-loss motivator for the two-thirds of American women who are overweight or obese.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures
Comment in
-
Re: Sustained Weight Loss and Risk of Breast Cancer in Women ≥50 Years: A Pooled Analysis of Prospective Data.J Natl Cancer Inst. 2020 Jul 1;112(7):769. doi: 10.1093/jnci/djaa026. J Natl Cancer Inst. 2020. PMID: 32101282 Free PMC article. No abstract available.
-
Reply to Flegal.J Natl Cancer Inst. 2020 Jul 1;112(7):770. doi: 10.1093/jnci/djaa027. J Natl Cancer Inst. 2020. PMID: 32101285 Free PMC article. No abstract available.
Similar articles
-
Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women.Cancer Causes Control. 2011 Apr;22(4):573-9. doi: 10.1007/s10552-011-9730-y. Epub 2011 Feb 13. Cancer Causes Control. 2011. PMID: 21327461
-
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.JAMA Oncol. 2015 Aug;1(5):611-21. doi: 10.1001/jamaoncol.2015.1546. JAMA Oncol. 2015. PMID: 26182172 Free PMC article. Clinical Trial.
-
Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):656-61. doi: 10.1158/1055-9965.EPI-04-0001. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767346
-
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3. Cochrane Database Syst Rev. 2023. PMID: 36971688 Free PMC article. Review.
-
Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.J Natl Cancer Inst. 2015 Mar 10;107(2):djv088. doi: 10.1093/jnci/djv088. Print 2015 Feb. J Natl Cancer Inst. 2015. PMID: 25757865 Review.
Cited by
-
Trem2 deficiency attenuates breast cancer tumor growth in lean, but not obese or weight loss, mice and is associated with alterations of clonal T cell populations.bioRxiv [Preprint]. 2024 Sep 27:2024.09.25.614811. doi: 10.1101/2024.09.25.614811. bioRxiv. 2024. PMID: 39386686 Free PMC article. Preprint.
-
Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conference.Cancer Med. 2024 Sep;13(18):e70255. doi: 10.1002/cam4.70255. Cancer Med. 2024. PMID: 39315735 Free PMC article. Review.
-
Weight gain after 35 years of age is associated with increased breast cancer risk: findings from a large prospective cohort study.Cancer Biol Med. 2024 Aug 27;21(8):651-5. doi: 10.20892/j.issn.2095-3941.2024.0172. Cancer Biol Med. 2024. PMID: 39205443 Free PMC article. No abstract available.
-
Association between weight change and serum anti-aging protein α-Klotho: a cross-sectional study in middle-aged and older adults.Sci Rep. 2024 Aug 11;14(1):18624. doi: 10.1038/s41598-024-69556-4. Sci Rep. 2024. PMID: 39128946 Free PMC article.
-
Exploring the multifaceted role of obesity in breast cancer progression.Front Cell Dev Biol. 2024 Jul 8;12:1408844. doi: 10.3389/fcell.2024.1408844. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39040042 Free PMC article. Review.
References
-
- World Health Organization. Obesity and Overweight Fact Sheet http://www.who.int/mediacentre/factsheets/fs311/en/. Published February 2018. Accessed April 21, 2018.
-
- Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and extreme obesity among adults aged 20 and over: United States, 1960-1962 through 2013-2014. https://www.cdc.gov/nchs/data/hestat/obesity_adult_13_14/obesity_adult_1... . Published July 2016. Accessed March 2, 2018.
-
- World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer. Continuous Update Project Report; 2017. wcrf.org/breast-cancer-2017.
-
- Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN268201600001C/HL/NHLBI NIH HHS/United States
- HHSN268201600003C/HL/NHLBI NIH HHS/United States
- P30 CA023074/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- P30 CA016087/CA/NCI NIH HHS/United States
- UM1 CA182934/CA/NCI NIH HHS/United States
- P30 ES000260/ES/NIEHS NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- HHSN268201600004C/HL/NHLBI NIH HHS/United States
- HHSN268201600018C/HL/NHLBI NIH HHS/United States
- U01 CA182913/CA/NCI NIH HHS/United States
- RC1 HL099355/HL/NHLBI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- U01 CA182934/CA/NCI NIH HHS/United States
- HHSN268201600002C/HL/NHLBI NIH HHS/United States
- R01 CA039742/CA/NCI NIH HHS/United States
